GeneDx Holdings Corp. Quarterly Selling and Marketing Expense in USD from Q1 2020 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate total amount of expenses directly related to the marketing or selling of products or services.
Summary
GeneDx Holdings Corp. quarterly/annual Selling and Marketing Expense history and growth rate from Q1 2020 to Q2 2024.
  • GeneDx Holdings Corp. Selling and Marketing Expense for the quarter ending June 30, 2024 was $16.6M, a 9.24% increase year-over-year.
  • GeneDx Holdings Corp. Selling and Marketing Expense for the twelve months ending June 30, 2024 was $65M, a 29.6% decline year-over-year.
  • GeneDx Holdings Corp. annual Selling and Marketing Expense for 2023 was $61M, a 50.1% decline from 2022.
  • GeneDx Holdings Corp. annual Selling and Marketing Expense for 2022 was $122M, a 8.28% increase from 2021.
  • GeneDx Holdings Corp. annual Selling and Marketing Expense for 2021 was $113M, a 78.4% increase from 2020.
Selling and Marketing Expense, Trailing 12 Months (USD)
Selling and Marketing Expense, Quarterly (USD)
Selling and Marketing Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $65M $16.6M +$1.4M +9.24% Apr 1, 2024 Jun 30, 2024 10-Q 2024-07-30
Q1 2024 $63.6M $16.1M +$2.63M +19.6% Jan 1, 2024 Mar 31, 2024 10-Q 2024-04-29
Q4 2023 $61M $15.6M -$13.7M -46.8% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-23
Q3 2023 $74.6M $16.8M -$17.6M -51.2% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-03
Q2 2023 $92.3M $15.2M -$17.6M -53.8% Apr 1, 2023 Jun 30, 2023 10-Q 2024-07-30
Q1 2023 $110M $13.5M -$12.2M -47.5% Jan 1, 2023 Mar 31, 2023 10-Q 2024-04-29
Q4 2022 $122M $29.2M -$1.41M -4.6% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-23
Q3 2022 $123M $34.4M +$6.23M +22.1% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-03
Q2 2022 $117M $32.8M +$14.3M +76.7% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 $103M $25.6M -$9.74M -27.5% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q4 2021 $113M $30.6M +$6.71M +28% Oct 1, 2021 Dec 31, 2021 10-K 2022-03-14
Q3 2021 $106M $28.2M +$12.9M +84.7% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 $93.1M $18.6M +$8.41M +82.7% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-15
Q1 2021 $84.7M $35.4M +$21.5M +156% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q4 2020 $63.2M $23.9M Oct 1, 2020 Dec 31, 2020 10-K 2022-03-14
Q3 2020 $15.2M Jul 1, 2020 Sep 30, 2020 10-K 2022-03-14
Q2 2020 $10.2M Apr 1, 2020 Jun 30, 2020 10-K 2022-03-14
Q1 2020 $13.8M Jan 1, 2020 Mar 31, 2020 10-K 2022-03-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.